206 results on '"Bazzato, G"'
Search Results
2. Loss of Ultrafiltration Capacity Role of Plasticizers
Catalog
Books, media, physical & digital resources
3. Functional and Histological Changes of Peritoneal Membrane in Long-Term Continuous Ambulatory Peritoneal Dialysis
4. Role of Peritoneal Membrane Hydration in UF Capacity of Patients on CAPD
5. Calcium Metabolism in Essential Hypertensive Patients Treated with Etozolin
6. The muscle in diabetes mellitus: A histologic (light and electron microscope) and biochemical study by means of needle biopsy
7. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition
8. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition
9. Phosphate Removal in Uremic Patients: Evaluation of Different Therapeutic Modalities
10. Vascular Stability and Temperature Monitoring in Patients Prone to Dialysis-Induced Hypotension
11. Prevention of Intra- and Postdialytic Hypertensive Crises by Captopril
12. Glycosaminoglycans prevent the functional and morfphological peritoneal derangment in an experimental model of peritoneal fibrosis
13. Glycosaminoglycans per os prevent peritoneal fibrosis in long term CAPD patients
14. Oral glycosaminoglycans (GAGs) ameliorate peritoneal transport in CAPD patients
15. Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial
16. UN CASO DI IPERPARATIROIDISMO PRIMITIVO IN ETA' PEDIATRICA
17. Experimental peritoneal fibrosis: Favorable effects of glycosaminoglycans (GAGS)
18. Assessment of the best compatible dialysis system: feasible application for bioelectrical impedance
19. Use of glycosaminoglycans to increase efficiency long-term continuous peritoneal dialysis
20. The renal glomerular and tubular function during dilatative myocardiopathy
21. A BAG–FILTER MODEL AS MACHINELESS ARTIFICIAL KIDNEY
22. COLD AS CARDIOVASCULAR STABILIZING FACTOR IN HEMODIALYSIS: HEMODYNAMIC EVALUATION
23. XYLITOL AS OSMOTIC AGENT IN CAPD: AN ALTERNATIVE TO GLUCOSE FOR UREMIC DIABETIC PATIENTS?
24. SPONTANEOUS ASCITES FILTRATION AND REINFUSION (SAFR) AS AMBULATORY CHRONIC TREATMENT FOR HEPATORENAL SYNDROME
25. PERITONITIS AND PERITONEAL DIALYSIS
26. A NEW CARTRIDGE FOR PHOSPHATE REMOVAL IN UREMIC PATIENTS
27. GLYCOSAMINOGLYCANS (GAGS) AMELIORATE PERITONEAL PERMSELECTIVITY IN LONG-TERM CARD PATIENTS
28. GLYCOSAMINOGLYCANS (GAGS) IMPROVE PERITONEAL TRANSPORT AND FIBROSIS IN RATS WITH PERITONEAL SCLEROSIS INDUCED BY DIETHYLEXYLPHTALATE (DEHP)
29. Plasticizers induced mononuclear cells interleukin 1 production: implications with peritoneal sclerosis
30. Calcium oxalate nephrolithiasis: defective oxalate transport
31. Clinical Benefits in Urea Evaluation. Role of Biosensor Monitoring
32. Traditional and Alternative Osmotic Agents in Peritoneal Dialysis
33. Vantaggi Clinici Nella Valutazione Dell'urea. Ruolo Del Monitoraggio Mediante Biosensore
34. Dialysis-induced hypotension (DIH) appears to be not mediated by nitric oxide (NO).
35. Associated Effect of Hepatic Hydroxymethylglutaryl Coenzyme A Reductase + Angiotensin Converting Enzyme Inhibitors on the Progression of Renal Failure in Hypertensive Subjects
36. Combined Hemodialysis-Hemoperfusion in the Treatment of Secondary Hyperparathyroidism of Uremic Patients
37. Agenti Osmotici Tradizionali e Alternativi in Dialisi Peritoneale
38. On-Line Bioelectric Impedance During Haemodialysis: Monitoring of Body Fluids and Cell Membrane Status
39. Intracellular pH and Electrolyte Content of Skeletal Muscle in Patients with Chronic Renal Acidosis.
40. Thyroidal Status in Uremia - Effects of Hemodialysis and CAPD
41. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
42. Thyroid function during hemodialysis and continuous ambulatory peritoneal dialysis
43. TSH Response to TRH in Hemodialysis and CAPD Patients
44. Thyroid Status and Nephron Loss - A study in Patients with Chronic Renal Failure, End Stage Renal Disease and/or on Hemodialysis
45. Effect of phthalate acid esters on transport in toad bladder membrane.
46. Thyroidal Status in Uremia - Effects of Hemodialysis and CAPD
47. Agenti Osmotici Tradizionali e Alternativi in Dialisi Peritoneale
48. Restoration of Ultrafiltration Capacity of Peritoneal Membrane in Patients on CAPD
49. VALUTAZIONE DEL METABOLISMO OSSEO IN PAZIENTI SOTTOPOSTI A DIALISI PERITONEALE
50. DUAL-PHOTON ABSORPTIOMETRY EVALUATION IN CHRONIC RENAL FAILURE
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.